Skip to main content
. 2023 Nov 10;15(22):4741. doi: 10.3390/nu15224741

Table 4.

Original SCAMP and neurodevelopmental follow-up cohort: mean (sd) potassium, phosphate and calcium intake (mmol/kg/d), and plasma levels (mmol/L) over days 1–14 along with the number of infants (%) receiving at least 1 supplementary infusion over the same period.

Mineral/Electrolyte Original RCT Neurodevelopmental FU
SCAMP (n = 74) Control (n = 76) p SCAMP (n = 38) Control (n = 41) p
Mean potassium intake 1.48 (0.30) 1.57 (0.29) 1.49 (0.26) 1.65 (0.19)
Mean phosphate intake 1.21 (0.31) 1.15 (0.21) 1.20 (0.27) 1.15 (0.21)
Mean calcium intake 0.89 (0.27) 0.93 (0.25) 0.89 (0.21) 0.98 (0.27)
Plasma potassium level 4.79 (0.51) 4.87 (0.57) 4.84 (0.44) 4.99 (0.56)
Plasma phosphate level 1.66 (0.19) 1.71 (0.24) 1.65 (0.16) 1.74 (0.26)
Plasma calcium level 2.16 (0.15) 2.20 (0.15) 2.17 (0.13) 2.21 (0.13)
Potassium supplement: n (%) 38 (51) 18 (24) 0.0007 15 (39) 8 (20) 0.08
Phosphate supplement: n (%) 54 (73) 36 (47) 0.0016 27 (71) 18 (44) 0.023
Calcium supplement: n (%) 8 (11) 6 (8) 0.59 4 (11) 2 (5) 0.42
Infants at 24–26 wks gestation SCAMP (n = 35) Control (n = 36) p SCAMP (n = 15) Control (n = 16) p
Potassium supplement: n (%) 21 (60) 11 (31) 0.017 7 (47) 2 (13) 0.053
Phosphate supplement: n (%) 32 (91) 18 (50) 0.0002 13 (87) 8 (50) 0.053
Calcium supplement: n (%) 3 (9) 3 (9) 1.0 4 (27) 2 (13) 0.39